JCTC vs NEM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JCTC exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the company trades at a deep discount to book value (P/B 0.36), this appears to be a value trap given the negative profit margins (-18.23%) and declining revenue growth (-6.60%). The combination of a 0/100 technical trend and consistent insider selling suggests a lack of confidence from both the market and company leadership. Operational decay is evident in the negative ROE and ROA, making the low valuation a reflection of risk rather than opportunity.
NEM shows bullish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Key strengths include strong valuation and growth metrics. Price trades at a 155.7% premium to fair value estimate ($44.73), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
JCTC vs NEM: Head-to-Head Comparison
This page compares Jewett-Cameron Trading Company Ltd. (JCTC) and Newmont Corporation (NEM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.